BLACK WEEKSFlacoane −15% · kituri −10% · restul −5%cu codulLivrare gratuită în Germania de la 200 €

Această pagină a fost tradusă automat și poate conține erori. Sunteți vorbitor nativ? Ne bucurăm să primim feedbackul și corecturile dumneavoastră.Trimiteți feedback

The Peptide Desk The Peptide Desk
Dutasteride, fotografie produs

Raport de laborator

PDF
Testat
Testat
Dutasteride 1mg × 100 Tabs
Laborator
Analiza Białek
Dată
October 2026
Rezultat
1.02 mg per tablet (1 mg label)
Nr. comandă
Parolă

Testat independent, verificabil cu parola direct la laborator.

Hair & Skin

Dutasteride

Hair & Skin

Comandă

Preț unitar - Livrare gratuită în Germania de la 200 € în timpul Black Weeks
  • DHL cu urmărire
  • Ambalare discretă

4.6 din 5 pe Trustpilot73 recenzii

Căutat și ca: Dutasterid

Pe scurt

Dutasteride în cifre

Valorile principale din lexiconul nostru. Trageți punctul de-a lungul curbei pentru a vedea cât rămâne, prin calcul, după o doză.

Articolul complet din lexicon

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5 weeks

Half-life ~5 weeks
After 10 weeks: 25 %
Week 550 %Week 1025 %Week 1512.5 %Week 253.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about5weeks

Class
5α-reductase inhibitor type 1 and type 2
Use
Oral1 tablet per day or every other day
Sizes
1 mg1 size in the shop

Informații

Totul despre Dutasteride

FAQ

Întrebări frecvente

Surse pentru fiecare răspuns: articolul din lexicon

Mai aveți o întrebare?

Scrieți-ne, echipa noastră vă ajută.

Is dutasteride approved?

Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.

How does dutasteride differ from finasteride?

Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.

What do the hair loss trials show?

The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.

What does research show for the prostate?

In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.

Does dutasteride lower prostate cancer risk?

In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.

Which side effects have been described?

In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.

Comparații

Cum se compară

Produse asemănătoare

Produse similare